Literature DB >> 21214521

Characterisation of TNF block haplotypes affecting the production of TNF and LTA.

J H Tan1, S E L Temple, C Kee, G W Waterer, C R T Tan, I Gut, P Price.   

Abstract

Polymorphisms in the central major histocompatibility complex (MHC) (particularly TNF and adjacent genes) associate with several immunopathological diseases and with susceptibility to pneumonia. The MHC is characterised by strong linkage disequilibrium (LD), so identification of loci affecting disease must be based on haplotypes. We have defined 31 tumour necrosis factor (TNF) block haplotypes (denoted FV1-31) in Caucasians, Asians and Australian Aboriginals. This study correlates the carriage of TNF block haplotypes with TNF and lymphotoxin alpha (LTA) protein production by peripheral blood mononuclear cells from 205 healthy Caucasian subjects, following in vitro stimulation with Streptococcus pneumoniae (S. pneumoniae; gram-positive bacteria), Escherichia coli (E. coli; gram-negative bacteria) or TNF over 4, 8 and 24 h. Fifteen haplotypes were present at >1%, accounting for 94.5% of the cohort. The haplotypes were grouped into five families based on common alleles. Following stimulation, cells from carriers of the FV10 haplotype (family 2) produced less LTA compared with non-FV10 carriers. Carriers of the FV18 haplotype (family 4) produced more LTA than other donors. Induction of TNF by S. pneumoniae following 24 h stimulation was also greater in donors with FV18. The FV18 haplotype associated with the 44.1 MHC ancestral haplotype (HLA-A2, -C5, -B44, -DRB1*0401 and -DQB1*0301) that has few disease associations. FV16 occurred in the 8.1 MHC haplotype (HLA-A2, B8, DR3) that is associated with multiple immunopathological diseases. FV16 did not affect TNF or LTA levels. The findings suggest that many genetic variations critical in vivo are not effectively modelled by short-term cultures.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214521     DOI: 10.1111/j.1399-0039.2010.01582.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Joint effect of gene-physical activity and the interactions among CRP, TNF-α, and LTA polymorphisms on serum CRP, TNF-α levels, and handgrip strength in community-dwelling elders in Taiwan - TCHS-E.

Authors:  Chia-Ing Li; Tsai-Chung Li; Li-Na Liao; Chiu-Shong Liu; Chuan-Wei Yang; Chih-Hsueh Lin; Jen-Hao Hsiao; Nai-Hsin Meng; Wen-Yuan Lin; Fang-Yang Wu; Cheng-Chieh Lin
Journal:  Age (Dordr)       Date:  2016-04-07

2.  Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans.

Authors:  Antonia L Wadley; Liesl M Hendry; Peter R Kamerman; Constance S N Chew; Patricia Price; Catherine L Cherry; Zané Lombard
Journal:  Eur J Hum Genet       Date:  2014-06-04       Impact factor: 4.246

3.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

Review 4.  Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.

Authors:  Yi Huang; Xi Yu; Lingyan Wang; Shengjun Zhou; Jie Sun; Nan Feng; Sheng Nie; Jingmi Wu; Feng Gao; Bing Fei; Jianyong Wang; Zhiqing Lin; Xianru Li; Leiting Xu; Xiang Gao; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

5.  TNF-Block Genotypes Influence Susceptibility to HIV-Associated Sensory Neuropathy in Indonesians and South Africans.

Authors:  Jessica Gaff; Fitri Octaviana; Prinisha Pillay; Huguette Gaelle Ngassa Mbenda; Ibnu A Ariyanto; June Anne Gan; Catherine L Cherry; Peter Kamerman; Simon M Laws; Patricia Price
Journal:  Int J Mol Sci       Date:  2020-01-07       Impact factor: 5.923

6.  Multiple selective sweeps of ancient polymorphisms in and around LTα located in the MHC class III region on chromosome 6.

Authors:  Michael C Campbell; Bryan Ashong; Shaolei Teng; Jayla Harvey; Christopher N Cross
Journal:  BMC Evol Biol       Date:  2019-12-02       Impact factor: 3.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.